Cargando…
Serum Calprotectin, CD26 and EGF to Establish a Panel for the Diagnosis of Lung Cancer
Lung cancer is the most lethal neoplasia, and an early diagnosis is the best way for improving survival. Symptomatic patients attending Pulmonary Services could be diagnosed with lung cancer earlier if high-risk individuals are promptly separated from healthy individuals and patients with benign res...
Autores principales: | Blanco-Prieto, Sonia, Vázquez-Iglesias, Lorena, Rodríguez-Girondo, Mar, Barcia-Castro, Leticia, Fernández-Villar, Alberto, Botana-Rial, María Isabel, Rodríguez-Berrocal, Francisco Javier, de la Cadena, María Páez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436352/ https://www.ncbi.nlm.nih.gov/pubmed/25992884 http://dx.doi.org/10.1371/journal.pone.0127318 |
Ejemplares similares
-
Highly Sensitive Marker Panel for Guidance in Lung Cancer Rapid Diagnostic Units
por: Blanco-Prieto, Sonia, et al.
Publicado: (2017) -
Calprotectin: a novel biomarker for the diagnosis of pleural effusion
por: Sánchez-Otero, N, et al.
Publicado: (2012) -
Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis
por: Blanco-Prieto, Sonia, et al.
Publicado: (2017) -
Levels of PEDF in Pleural Effusions from Lung Adenocarcinoma and Benign Disease Patients
por: Sánchez-Otero, Nuria, et al.
Publicado: (2013) -
Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial
por: Botana-Rial, Maribel, et al.
Publicado: (2020)